Kalkine has a fully transformed New Avatar.
GetSwift Ltd
· Commenced trading on ASX: GetSwift Ltd (ASX: GSW) started trading on the Australian Securities Exchange on December 09, 2016 and rose about 50% on debut. GSW has raised A$5 million at A$0.20 per share through an initial public offer which got over subscribed, as led by Cygnet Capital. The IPO got strong support from the domestic and the international institutional investors that includes Regal Emerging Companies Fund. Moreover, GSW is expanding across a number of sectors and across the geographies in US, Asia, European Union and Middle East. Additionally, GSW will focus on scaling resources to optimize on boarding, deployment and geographic reach and would continue to develop the user interface and optimization of the user experience of the GSW platform.
· Recommendation: We give a “Speculative Buy” recommendation at the current price of – $ 0.30
Commitments of funds (Source: Company Reports)
Fastbrick Robotics Ltd
FBR Details
· Funds Raised successfully: Fastbrick Robotics Ltd (ASX: FBR) stock rose over 26.4% on December 09, 2016 driven by their successful raising of funds of $8 million via a Strategic Cornerstone Investor Placement with Hunter Hall Investment Management Limited. After the completion of the placement, Hunter Hall’s holding in FBR represents 17.2% of shares on issue. The funds raised will be used to complete the Hadrian X™Commercial Prototype, for which the delivery is scheduled in 2017. Moreover, FBR is now fully funded into 2018 and the cash reserves will exceed $10 million.
· Recommendation: FBR stock rose over 31.82% (as of December 08, 2016) in the last three months. There is still time to see potential growth from the company’s technology platform, and accordingly, we give an “Expensive” recommendation at the current price of – $ 0.11
Disclaimer
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated pages are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd currently hold positions in: BHP, BKY, KCN, PDN, and RIO. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.